Angela R I Meyrelles1, Juliana D Siqueira2, Cristina B Hofer3, Tomaz P Costa3, Andrea P Azevedo3, Bruna V Guimarães4, Héctor N Seuánez5, Marcelo A Soares5, Gutemberg Almeida1, Esmeralda A Soares2, Elizabeth S Machado6. 1. Instituto de Ginecologia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil; Programa de Pós Graduação em Ciências Cirúrgicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil. 2. Programa de Genética, Instituto Nacional de Câncer, Rio de Janeiro, Brazil. 3. Instituto de Puericultura e Pediatria Martagão Gesteira, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil. 4. Faculdade de Medicina, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil. 5. Programa de Genética, Instituto Nacional de Câncer, Rio de Janeiro, Brazil; Departamento de Genética, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil. 6. Instituto de Puericultura e Pediatria Martagão Gesteira, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil; Departamento de Genética, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil. Electronic address: emachado@infolink.com.br.
Abstract
OBJECTIVE: HIV(+) pregnant women are at a higher risk of HPV infection and development of cervical cancer. Our objectives were to assess the prevalence and HPV types in HIV(+) pregnant women and to identify risk factors for HPV infection and cytological abnormalities. METHODS: Cervicovaginal smears were collected during pregnancy from 140 women. Partial HPV L1 gene and the exon 4 of the human TP53 gene (containing codon 72) were PCR-amplified and sequenced. Amplified products indicating multiple HPV infection were further cloned and sequenced. The association of demographic, obstetric and HIV-related clinical variables with HPV infection and cervical lesions was tested by univariate analyses, and significant factors were subsequently tested by logistic regression multivariate analysis. RESULTS: HPV DNA tested positive for 118 patients and HPV types were identified in 104 samples. Twenty-eight different types were found, HPV-16 and HPV-58 being the most prevalent. High-risk types were present in 79.8% of samples and multiple infections in 16.3%. Abnormal cervical smears were found in 44 patients (31.4%). Absolute CD4(+) T-cell counts below 350 were associated with HPV infection. Younger age was associated with cervical abnormalities and higher CD4(+) T-cell count was an apparent protective factor. CONCLUSIONS: We found a high prevalence of HPV infection and high-risk types in this cohort. Our results highlighted the relevance of immune system integrity rather than TP53 variants for protecting this highly vulnerable population to HPV infection and carcinogenesis.
OBJECTIVE: HIV(+) pregnant women are at a higher risk of HPV infection and development of cervical cancer. Our objectives were to assess the prevalence and HPV types in HIV(+) pregnant women and to identify risk factors for HPV infection and cytological abnormalities. METHODS: Cervicovaginal smears were collected during pregnancy from 140 women. Partial HPV L1 gene and the exon 4 of the humanTP53 gene (containing codon 72) were PCR-amplified and sequenced. Amplified products indicating multiple HPV infection were further cloned and sequenced. The association of demographic, obstetric and HIV-related clinical variables with HPV infection and cervical lesions was tested by univariate analyses, and significant factors were subsequently tested by logistic regression multivariate analysis. RESULTS: HPV DNA tested positive for 118 patients and HPV types were identified in 104 samples. Twenty-eight different types were found, HPV-16 and HPV-58 being the most prevalent. High-risk types were present in 79.8% of samples and multiple infections in 16.3%. Abnormal cervical smears were found in 44 patients (31.4%). Absolute CD4(+) T-cell counts below 350 were associated with HPV infection. Younger age was associated with cervical abnormalities and higher CD4(+) T-cell count was an apparent protective factor. CONCLUSIONS: We found a high prevalence of HPV infection and high-risk types in this cohort. Our results highlighted the relevance of immune system integrity rather than TP53 variants for protecting this highly vulnerable population to HPV infection and carcinogenesis.
Authors: Jessica L Castilho; José Eduardo Levi; Paula M Luz; Mary Catherine Cambou; Tazio Vanni; Angela de Andrade; Mônica Derrico; Valdiléa G Veloso; Beatriz Grinsztejn; Ruth K Friedman Journal: BMC Cancer Date: 2015-06-23 Impact factor: 4.430
Authors: Angela Ri Meyrelles; Juliana D Siqueira; Pâmela P Dos Santos; Cristina B Hofer; Ronir R Luiz; Héctor N Seuánez; Gutemberg Almeida; Marcelo A Soares; Esmeralda A Soares; Elizabeth S Machado Journal: Mem Inst Oswaldo Cruz Date: 2016-02 Impact factor: 2.743
Authors: Gislaine Curty; Raquel L Costa; Juliana D Siqueira; Angela I Meyrelles; Elizabeth S Machado; Esmeralda A Soares; Marcelo A Soares Journal: Sci Rep Date: 2017-12-12 Impact factor: 4.379
Authors: Juliana D Siqueira; Gislaine Curty; Deng Xutao; Cristina B Hofer; Elizabeth S Machado; Héctor N Seuánez; Marcelo A Soares; Eric Delwart; Esmeralda A Soares Journal: Viruses Date: 2019-05-07 Impact factor: 5.048